Tectonic Therapeutic, Inc. (TECX)
Healthcare
Biotechnology
—
27.90 $
-0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Tectonic Therapeutic, Inc. (TECX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -60 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.3 | -16 | -38 | -68 | -99 | -12 | -97 | -41 | -59 | -60 | |
| – | 0.0 | 0.4 | 0.9 | 1.2 | 0.4 | 0.0 | 1.5 | 1.6 | 1.4 | |
| – | – | – | – | – | 0.6 | 0.0 | 1.1 | 3.5 | 10 | |
| 0.7 | 1.6 | 4.2 | -2.2 | 4.2 | 1.9 | -7.4 | -0.6 | -10 | -0.1 | |
| 0.0 | 0.4 | 1.8 | 1.6 | 1.2 | 2.1 | 0.3 | 0.3 | 0.2 | 0.2 | |
| 0.0 | -0.4 | -1.8 | -1.6 | -1.2 | -2.1 | -0.3 | -0.3 | -0.2 | -0.1 | |
| – | – | – | – | – | 3.6 | -0.4 | -0.5 | -0.5 | -0.5 | |
| 8.7 | 17 | 160 | 130 | 173 | 41 | 0.3 | 34 | 172 | 173 | |
| 5.4 | 0.6 | 120 | 61 | 73 | 27 | -97 | -7.2 | 112 | 113 | |
| -3.3 | -17 | -39 | -69 | -100 | -15 | -97 | -41 | -59 | -60 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.